Skip to search.
 FTSE 100 Up 0.26%

KaloBios Pharmaceuticals, Inc. (KBIO)

-NasdaqGM
0.53 Down 0.02(3.59%) 22 May 21:00
Add to Portfolio
Prev Close:0.55
Open:0.54
Bid:0.52 x 2800
Ask:0.59 x 5000
1y Target Est:5.00
Beta:4.28
Earnings Date:5 Aug - 10 Aug (Est.)
Day's Range:0.51 - 0.56
52wk Range:0.36 - 2.45
Volume:532,790
Avg Vol (3m):1,228,400
Market Cap:17.51m
P/E (ttm):N/A
EPS (ttm):-1.15
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for KBIO at this time.

Comparison

Symbol% ChgMkt Cap
KBIODown 3.59%17.51m
VRTXUp 0.02%30.49b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.30
Quarterly EPS Est (Jun-15) :-0.29
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

KaloBios Pharmaceuticals, Inc., a biopharmaceutical company, develops monoclonal antibody therapeutics for the treatment of cancer in the United States. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback